Anjali Labtech IPO
Anjali Labtech IPO — date, issue size, SEBI status & UDRHP details 2026
Anjali Labtech filed its updated draft red herring prospectus (UDRHP) with SEBI on 25 Sep 2026, the public version of a draft it first filed confidentially, for an IPO of a fresh issue of up to ₹925 crore and an offer for sale of up to ₹300 crore. SEBI has issued its observations on the confidential draft, which clears the IPO for launch within 12 months. The price band, lot size and IPO dates are not announced yet.
Anjali Labtech makes MPCVD machines that grow lab-grown diamonds in Surat, and also sells polished lab-grown diamonds and studded jewellery. Revenue from operations grew from Rs 223.19 crore in FY2024 to Rs 615.51 crore in FY2026.
Where the Anjali Labtech IPO stands
From draft to listing. Today is 6 October 2026.
- UDRHP filed 25 Sep 2026
- SEBI observations Done
- RHP & price band TBA
- Bidding TBA
- Listing TBA
| UDRHP filed with SEBI | 25 Sep 2026 |
|---|---|
| SEBI status | SEBI approved |
| RHP, price band & dates | Not announced |
Anjali Labtech IPO details
The offer as the UDRHP describes it. Terms can change in the RHP.
| Issue type | Fresh issue and offer for sale |
|---|---|
| Filing route | Confidential pre-filing with SEBI, then the public UDRHP |
| Fresh issue | Up to ₹925 Cr |
| Offer for sale | Up to ₹300 Cr |
| Total issue size | ₹1,225 Cr |
| Pre-IPO placement | Up to ₹185 Cr (reduces the fresh issue) |
| Face value | ₹5 per share |
| Proposed listing | BSE, NSE |
| Price band | Not announced (comes with the RHP) |
| Lot size | Not announced |
| IPO dates | Not announced |
| Book running lead managers | IIFL Capital Services Limited, Axis Capital Limited |
| Registrar | MUFG Intime India Private Limited |
Who is selling in the offer for sale
| Selling shareholder | Type | Offering | Avg. cost / share |
|---|---|---|---|
| Madhubhai Samajubhai Raddiya | Promoter Group | Up to Rs 118.75 crore | Nil |
| Shilpaben Rajanibhai Radadiya | Promoter Group | Up to Rs 106.25 crore | Nil |
| Nehalben Sandipkumar Radadiya | Promoter Group | Up to Rs 75.00 crore | Nil |
The weighted average cost of acquisition of the two promoters and the three promoter group selling shareholders is nil per equity share, as certified by the company's chartered accountants, and the weighted average cost of all shares transacted in the last three years was Rs 0.23.
Strengths & risks
The case for and against, from the UDRHP's own numbers and risk factors.
Strengths · 7
- 01The document cites the Wazir report for an estimated 36% global share by volume in MPCVD machines used to grow lab-grown diamonds as of 31 March 2026, and about 41% in India.
- 02Revenue from operations grew from Rs 223.19 crore in FY2024 to Rs 615.51 crore in FY2026, a rise of 30.27% in FY2026 after 111.71% in FY2025.
- 03All five revenue lines are made in-house, with MPCVD machinery at 31.84% of FY2026 revenue and polished diamonds at 39.79%, so no single product carried more than two fifths.
- 04The company supplied 2,253 customers in FY2026, including 807 outside India across 23 countries, against 14 countries in Fiscal 2024.
- 05Return on equity was 47.99% and return on capital employed 46.23% in FY2026, with a debt to equity ratio of 0.27.
- 06Cash flow from operating activities was Rs 306.95 crore in FY2026, above the profit after tax of Rs 200.92 crore for the same year.
- 07Promoters and the promoter group hold 99.53% of the pre-offer equity and are selling shares worth up to Rs 300.00 crore in the offer.
Risks · 10
- 01The company was incorporated in Fiscal 2022 and its only track record is profit after tax of Rs 200.92 crore in FY2026, Rs 146.79 crore in FY2025 and Rs 90.06 crore in FY2024.
- 02The top 10 customers gave 59.37% of FY2026 revenue from operations and the single largest customer gave 31.90%.
- 03MPCVD machine sales were 31.84% of FY2026 revenue, and the company sells those machines to the same lab-grown diamond industry whose output it also sells, so one slowdown can hit both lines.
- 04Export sales were 34.11% of FY2026 revenue, and the document names United States tariffs and trade measures on diamond products sourced from India as a risk.
- 05The EBITDA margin fell from 49.23% in FY2024 to 42.93% in FY2026 and the profit after tax margin from 39.52% to 32.18%, while wholesale lab-grown diamond prices per carat corrected.
- 06A claim of AED 45,640,722, equal to Rs 118.61 crore, is pending against the company before a UAE court, filed by Muegge GmBH over dealings of another defendant.
- 07Total borrowings rose from Rs 18.95 crore in Fiscal 2024 to Rs 137.83 crore in FY2026, and Rs 75.00 crore of the fresh issue is earmarked to repay borrowings.
- 08Net working capital days rose from 47 in Fiscal 2024 to 62 in FY2026, so growth is absorbing more working capital.
- 09The statutory auditors and the previous statutory auditors included observations under the Companies (Auditor's Report) Order, 2020 for FY2026, FY2025 and FY2024.
- 10The document states that the company has no exact comparable listed peer in India or globally, and credit ratings in the past were withdrawn or assigned under Issuer Not Cooperating status.
Anjali Labtech financials
Restated figures in ₹ crore, as reported in the UDRHP.
| ₹ crore | 31 Mar 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Revenue from Operations | 615.51 | 472.50 | 223.19 |
| EBITDA | 264.22 | 184.64 | 109.87 |
| Profit After Tax | 200.92 | 146.79 | 90.06 |
| Net Worth | 518.96 | 318.56 | 172.33 |
| Total Borrowing | 137.83 | 111.94 | 18.95 |
Key ratios (FY26)
P/E and market capitalisation need the price band and are added when the RHP is out.
Where the IPO money goes
₹673.83 crore of the fresh issue is earmarked to named objects; offer for sale proceeds go to the selling shareholders, not the company.
About Anjali Labtech
Revenue comes from five streams. In FY2026, MPCVD machinery brought Rs 196.00 crore or 31.84% of revenue from operations, polished diamonds Rs 244.88 crore or 39.79%, studded jewellery Rs 110.97 crore or 18.03%, colour enhancement services Rs 34.11 crore or 5.54%, and others, which covers machine parts and scrap, Rs 29.54 crore or 4.80%. Jewellery and colour enhancement services started only in Fiscal 2024 and the others segment only in Fiscal 2026, so the revenue mix is still changing every year.
In FY2026 the company supplied 2,253 customers, of which 807 were outside India. Export revenue was Rs 209.94 crore, or 34.11% of revenue from operations, across 23 countries, against Rs 227.09 crore and 48.06% across 28 countries in FY2025. It sold 1,446 MPCVD machines in FY2026, up from 994 in Fiscal 2024, along with 3,60,953 carats of polished diamonds and 1,02,406 grams of studded jewellery. Seven manufacturing facilities, all on leased premises, are in Surat, Gujarat.
Profit after tax rose from Rs 90.06 crore in FY2024 to Rs 200.92 crore in FY2026. The EBITDA margin was 42.93% in FY2026 against 49.23% in FY2024, so profit grew while the margin came off its FY2024 level. Net worth stood at Rs 518.96 crore and total borrowings at Rs 137.83 crore as on 31 March 2026, a debt to equity ratio of 0.27. Cash flow from operating activities was Rs 306.95 crore in FY2026 against Rs 49.62 crore in FY2025, while the investing outflow was Rs 321.49 crore.
The company was incorporated in Fiscal 2022, so its track record is short. The offer is a fresh issue of up to Rs 925.00 crore and an offer for sale of up to Rs 300.00 crore by three promoter group shareholders, a total of up to Rs 1,225.00 crore. Promoters and the promoter group together hold 99.53% of the pre-offer capital. The company may also raise up to Rs 185.00 crore in a pre-IPO placement, which would be reduced from the fresh issue.
The industry
The Wazir report in the document puts global lab-grown diamond trade at USD 3.3 billion in CY 2024, up from USD 0.5 billion in CY 2018, a CAGR of 37%. India's rough lab-grown diamond market is estimated at 17 to 19 million carats in FY 2026 and is projected to grow at a CAGR of 21 to 24% to 40 to 41 million carats by FY 2030. Operational MPCVD machines in India have grown from about 1,200 units in FY 2020 to an estimated 13,700 units in FY 2026, and India accounts for about 87% of global MPCVD machine manufacturing, with 40 to 50 domestic manufacturers of whom the top 5 hold around 80% of the domestic market. The report also records that wholesale lab-grown diamond prices per carat corrected as production capacity expanded in India and China.
Customer concentration: Top 5 customers gave 49.91% of FY2026 revenue from operations (49.60% in FY2025), and the top 10 customers gave 59.37%.
Promoters & management
The two promoters hold 43.45% of the pre-offer equity share capital and the promoter group a further 56.08%, taking promoter and promoter group holding to 99.53%.
| Name | Role |
|---|---|
| Rajnikant M Radadiya | Chairman and Whole-time Director |
| Sandipbhai Madhubhai Radadiya | Managing Director |
| Gopal Chunibhai Radadiya | Whole-time Director |
| Sunil Kumar Bansal | Independent Director |
| Shailendra Kumar Shukla | Independent Director |
| Kavita Rakesh Shah | Independent Director |
| Priyanka Naman Shah | Chief Financial Officer |
| Sakhavala Kaushik Parsotambhai | Company Secretary and Compliance Officer |
The bankers & the filings
Who is running the issue, and the SEBI documents this page is built from.
Lead Manager Track Record
How the book-running lead managers on this issue have priced their past IPOs, measured on listing day.
Axis Capital
29 issues handledBest listing: Moneyview (+61.8%). Weakest: Clean Max Enviro Energy Solutions (-8.8%).
IIFL Capital Services Limited
30 issues handledBest listing: Orient Cables (India) (+65.4%). Weakest: Acevector (-11.5%).
Listing gain compares the listing-day opening price with the issue price, using the IPOs on IPO Guru that this lead manager has taken to market. A strong record reflects how the banker has priced past issues — it is not a forecast for this one. See every issue they have handled on the lead managers page.
Anjali Labtech IPO: frequently asked
When will the Anjali Labtech IPO open?
The Anjali Labtech IPO dates are not announced yet. SEBI has issued its observations on the confidential draft, which clears the IPO for launch within 12 months. The company announces the dates and price band after it files its red herring prospectus (RHP) with the Registrar of Companies, usually a week or two before bidding opens. This page switches to the full IPO page with dates, price band and lot size as soon as that happens.
What is the Anjali Labtech IPO price band?
The price band is not announced yet. It is set by the company and its lead managers and published with the RHP, a few days before the issue opens. The DRHP fixes only the face value of ₹5 per share.
How big is the Anjali Labtech IPO?
Anjali Labtech filed its updated draft red herring prospectus (UDRHP) with SEBI on 25 Sep 2026, the public version of a draft it first filed confidentially, for an IPO of a fresh issue of up to ₹925 crore and an offer for sale of up to ₹300 crore. The DRHP puts the total at about ₹1,225 crore.
Has SEBI approved the Anjali Labtech IPO?
SEBI has issued its observations on the confidential draft, which clears the IPO for launch within 12 months. SEBI observations are valid for 12 months; the IPO has to open within that window or the company must file again.
What is the Anjali Labtech IPO GMP?
There is no grey market premium to report before the price band is announced. IPO Guru starts tracking the Anjali Labtech IPO GMP once the RHP and price band are out.
What will Anjali Labtech do with the IPO money?
As per the UDRHP: Capital expenditure for manufacturing and captive installation of MPCVD Machines to grow rough lab-grown diamonds in-house (₹524.56 crore); Construction and development of Anjali Corporate House at Moje Kosmada, Surat, Gujarat (₹74.27 crore); Prepayment or repayment of a portion of certain outstanding borrowings (₹75 crore); General corporate purposes.
Who are the lead managers of the Anjali Labtech IPO?
The book running lead managers are IIFL Capital Services Limited, Axis Capital Limited. MUFG Intime India Private Limited is the registrar.
Is Anjali Labtech profitable?
Yes. Profit after tax was Rs 200.92 crore in FY2026, Rs 146.79 crore in FY2025 and Rs 90.06 crore in FY2024.
What does Anjali Labtech make?
It makes MPCVD machines used to grow rough lab-grown diamonds, grows and polishes lab-grown diamonds in-house, makes lab-grown diamond studded jewellery and provides colour enhancement services.
How many MPCVD machines does Anjali Labtech sell in a year?
It sold 1,446 MPCVD machines in FY2026, 1,152 in FY2025 and 994 in Fiscal 2024.
Who owns Anjali Labtech before the IPO?
Promoters Rajnikant M Radadiya and Sandipbhai Madhubhai Radadiya hold 43.45% and the promoter group holds 56.08%, a combined 99.53%.
Other companies in the IPO pipeline
Mainboard companies with drafts filed with SEBI, same bankers first.
Know the day the price band is out.
We track every mainboard draft from SEBI filing to listing. When Anjali Labtech files its RHP, this page becomes the full IPO page with dates, price band, lot size, GMP and subscription.
Not investment advice. Figures are from the company's draft offer document filed with SEBI and may change in the RHP.